| Notifications | Preventive Care Services | MA00.003z | 6/1/2024 10:00 AM | 7/1/2024 | | | 6/1/2024 | Medical Necessity Criteria;Medical Coding | | |
| Notifications | Surgical Procedures of the Eyelid and Brow | MA11.047e | 6/18/2024 9:00 AM | 9/16/2024 | | | 6/18/2024 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Tafasitamab-cxix (Monjuvi®) | MA08.138c | | 6/3/2024 | | | 6/3/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Outpatient Physical Medicine and Rehabilitation Services- Physical Therapy (PT) and Occupational Therapy (OT) | MA10.003j | | 1/15/2024 | | | 6/3/2024 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Not Medically Necessary Services and Obsolete or Unreliable Diagnostic Tests | MA00.001d | | 6/3/2024 | | | 6/3/2024 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Updated Policies | Risankizumab-rzaa (Skyrizi®) for intravenous use | MA08.153b | | 6/3/2024 | | | 6/3/2024 | Medical Coding | | |
| Updated Policies | Reimbursement for the Administration of Immunizations | MA07.019c | | 6/3/2024 | | | 6/3/2024 | Medical Coding | | |
| Updated Policies | Compression Garments | MA05.045e | | 6/3/2024 | | | 6/3/2024 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Reduction Mammoplasty | MA11.069f | | 6/3/2024 | | | 6/3/2024 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Biofeedback Therapy | MA07.010c | | 4/1/2024 | | | 6/17/2024 | Medical Coding | | |
| Updated Policies | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane® for Injectable Suspension) | MA08.049m | | 6/17/2024 | | | 6/17/2024 | Medical Necessity Criteria | | |
| Updated Policies | Solid Organ Transplantation and Procurement Cost of Organs and Tissues | MA11.033c | | 6/17/2024 | | | 6/17/2024 | Coverage and/or Reimbursement Position | | |
| Updated Policies | Anifrolumab-fnia (Saphnelo®) | MA08.140c | | 6/17/2024 | | | 6/17/2024 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Cataract Surgery | MA11.054e | | 6/17/2024 | | | 6/17/2024 | Medical Coding | | |
| Updated Policies | Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring | MA07.026p | 3/22/2024 11:00 AM | 6/24/2024 | | | 6/24/2024 | Medical Coding | | |
| Reissue Policies | Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management | MA01.008b | | 1/1/2024 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Home-Use Light Box for the Treatment of Seasonal Affective Disorder (SAD) | MA05.022a | | 1/1/2023 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Surgery for Gynecomastia | MA11.110a | | 12/19/2022 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Photodynamic Therapy Using Verteporfin (Visudyne®) | MA07.003d | | 5/7/2018 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Smell and Taste Dysfunction Testing | MA07.043a | | 5/7/2018 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Cranial Electrotherapy Stimulation | MA05.066d | | 1/2/2024 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA]) | MA07.056d | | 7/1/2019 | 6/12/2024 | | 6/12/2024 | | | |
| Reissue Policies | Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, and Antiepileptics | MA06.029a | | 1/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Air Ambulance Services | MA12.007b | | 1/1/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Never Events and Preventable Serious Adverse Events | MA00.039e | | 1/1/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Photocoagulation of Macular Drusen | MA11.063a | | 6/14/2017 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Injectable Dermal Fillers for Cosmetic Procedures | MA05.021b | | 7/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | X-rays Associated with Fractures in the Office Setting | MA00.031f | | 12/5/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation | MA09.021e | | 1/1/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis | MA11.116a | | 1/1/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Radiologic Guidance and/or Supervision and Interpretation of a Procedure | MA00.019j | | 8/1/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Hyperbaric Oxygen Therapy | MA07.001b | | 1/1/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Laboratory-Based Vestibular Function Testing | MA07.031b | | 1/1/2021 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Corneal Pachymetry Using Ultrasound | MA07.046g | | 9/19/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Intrauterine Systems (IUSs) (e.g., Mirena®, Skyla®, Liletta®, Kyleena®) | MA07.025f | | 1/2/2024 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Reimbursement for an Intraocular Lens | MA11.043a | | 1/18/2021 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Refractive Keratoplasty | MA11.008e | | 7/1/2022 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Topical Oxygenation | MA07.011a | | 4/8/2015 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Sentinel Lymph Node Biopsy and Mapping | MA11.068e | | 1/1/2023 | 6/26/2024 | | 6/26/2024 | | | |
| Reissue Policies | Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments | MA06.025q | | 7/1/2023 | 6/26/2024 | | 6/26/2024 | | | |